person
Michael F.
- Country
- Germany
- Department
- Clinic for Paediatric and Adolescent Medicine
Research Overview
assignment
29
Clinical Trials ·
- ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study (The ACTION Study)
- International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Interfant-21: International collaborative treatment protocol for infants under one year with KMT2A-rearranged acute lymphoblastic leukemia or mixed phenotype acute leukemia
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
255
Sites with multiple studies
Has run more than one trial at 255 of 380 partner sites.
Specializations
Pediatric Hematologic Malignancies
Specializes in treating complex blood cancers in children, with particular focus on acute lymphoblastic leukemia and lymphoblastic lymphoma. Conducts innovative research in targeted therapies and immunotherapy approaches.
- Philadelphia chromosome-positive ALL
- Relapsed/refractory leukemias
- ALK-positive lymphomas
Pediatric Brain Tumors
Leads clinical research in various types of childhood brain tumors, focusing on medulloblastoma, ependymoma, and high-grade gliomas.
- Diffuse intrinsic pontine glioma
- Atypical teratoid/rhabdoid tumors
- Low-grade gliomas
Solid Tumors
Investigates novel therapeutic approaches for various pediatric solid tumors, with expertise in rhabdomyosarcoma, neuroblastoma, and Ewing sarcoma.
- Hepatoblastoma
- Hepatocellular carcinoma
- Renal tumors
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.